Salmonella enterica serotype Paratyphi A carrying CTX-M-15 type extended-spectrum beta-lactamase isolated from a Japanese traveller returning from India, Japan, July 2013

M Mawatari; Y Kato; K Hayakawa; M Morita; K Yamada; K Mezaki; T Kobayashi; Y Fujiya; S Kutsuna; N Takeshita; S Kanagawa; M Ohnishi; H Izumiya; N Ohmagari

doi:10.2807/1560-7917.es2013.18.46.20632

Salmonella enterica serotype Paratyphi A carrying CTX-M-15 type extended-spectrum beta-lactamase isolated from a Japanese traveller returning from India, Japan, July 2013

Euro Surveill. 2013 Nov 14;18(46):20632. doi: 10.2807/1560-7917.es2013.18.46.20632.

Authors

M Mawatari¹, Y Kato, K Hayakawa, M Morita, K Yamada, K Mezaki, T Kobayashi, Y Fujiya, S Kutsuna, N Takeshita, S Kanagawa, M Ohnishi, H Izumiya, N Ohmagari

Affiliation

¹ Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

PMID: 24256887
DOI: 10.2807/1560-7917.es2013.18.46.20632

Abstract

Emerging drug resistance in Salmonella Typhi and S. Paratyphi is a substantial public health concern. We report what appears to be the first case and isolation of multidrug resistant S. Paratyphi A carrying CTXM-15-type extended-spectrum beta-lactamase from a Japanese traveller returning from India.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anti-Bacterial Agents / pharmacology
Drug Resistance, Multiple, Bacterial
Electrophoresis, Gel, Pulsed-Field
Humans
India
Japan
Microbial Sensitivity Tests
Paratyphoid Fever / diagnosis
Paratyphoid Fever / drug therapy
Polymerase Chain Reaction
Salmonella Infections / diagnosis
Salmonella Infections / drug therapy
Salmonella paratyphi A / enzymology
Salmonella paratyphi A / genetics*
Salmonella paratyphi A / isolation & purification*
Serotyping
Travel
Treatment Outcome
beta-Lactamases

Substances

Anti-Bacterial Agents
beta-Lactamases